Iovance Biotherapeutics Inc

The current institutional shareholding score of Iovance Biotherapeutics Inc is 5.00, ranking 133 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 69.13%, representing a quarter-over-quarter increase of 11.55%. The largest institutional shareholder is ETHSX, holding a total of 423.34K shares, representing 0.12% of shares outstanding, with 78.57% increase in holdings.